Computer Aided Detection of Polyps in Colonoscopy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04754347 |
Recruitment Status :
Completed
First Posted : February 15, 2021
Last Update Posted : December 1, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Colorectal Polyp | Device: Computer Aided Detection device | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 1472 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Primary Purpose: | Screening |
Official Title: | Randomized, Controlled Trial of a Computer Aided Detection Device in Standard Colonoscopy |
Actual Study Start Date : | January 22, 2021 |
Actual Primary Completion Date : | October 31, 2021 |
Actual Study Completion Date : | October 31, 2021 |
Arm | Intervention/treatment |
---|---|
No Intervention: Control
Routine Colonoscopy
|
|
Experimental: Experimental
Routine Colonoscopy with the use of Skout
|
Device: Computer Aided Detection device
The Computer Aided Detection device, Skout, is designed to help endoscopists detect potential colorectal polyps during colonoscopies. The system performs automated real-time analysis on endoscopic video data to identify potential polyps and produces an informational visual aid around the appropriate sections of the video frames on a display monitor. |
- Adenomas per colonoscopy [ Time Frame: At the end of the procedure, 1 day ]The total number of adenomas detected divided by the total number of colonoscopies.
- Positive predictive value [ Time Frame: At the end of the procedure, 1 day ]The total number of adenomas and serrated lesions detected divided by the total number of extractions.
- Adenoma detection rate [ Time Frame: At the end of the procedure, 1 day ]The percentage of participants aged ≥50 years undergoing first-time screening colonoscopy who have one or more conventional adenomas detected.
- Sessile serrated lesions detected [ Time Frame: At the end of the procedure, 1 day ]The total number of polyps with histology or serrated adenoma, traditional serrated adenoma or serrated lesion with cytological dysplasia, excluding hyperplastic polyps.
- Colorectal cancer surveillance interval [ Time Frame: At the end of the procedure, 1 day ]The mean recommended timeframe for follow up colonoscopy.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 40 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
Participants will be eligible for this study if they are:
- Undergoing colonoscopy with screening, surveillance, or diagnostic indications.
- Undergoing a procedure by a participating endoscopist.
- Have given informed consent.
Exclusion Criteria
Participants will not be eligible for this study if they:
- Have a history of inflammatory bowel disease.
- Have a history of familial adenomatous polyposis.
- Are under the age of 40.
- Have had a colonoscopy within the previous three (3) years.
- Undergoing diagnostic colonoscopy with high-risk indications including iron deficiency anemia, abnormal CT imaging, unexplained weight loss, Lynch Syndrome, blood in stool or FIT positive test.
- Entered with poor bowel preparation (inadequate for procedure as assessed by the Investigator).
- Use anti-platelet agents or anticoagulants that preclude the removal of polyps during the procedure.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04754347
United States, Massachusetts | |
Massachusetts General Hospital | |
Boston, Massachusetts, United States, 02114 | |
Boston Medical Center | |
Boston, Massachusetts, United States, 02118 | |
Mount Auburn Hospital | |
Cambridge, Massachusetts, United States, 02138 | |
United States, Minnesota | |
MNGI Digestive Health | |
Plymouth, Minnesota, United States, 55446 | |
United States, New Hampshire | |
Concord Endoscopy Center | |
Concord, New Hampshire, United States, 03301 |
Principal Investigator: | Aasma Shaukat, MD, MPH | University of Minnesota |
Responsible Party: | Iterative Scopes, Inc |
ClinicalTrials.gov Identifier: | NCT04754347 |
Other Study ID Numbers: |
Pro00047634 |
First Posted: | February 15, 2021 Key Record Dates |
Last Update Posted: | December 1, 2021 |
Last Verified: | November 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Device Product Not Approved or Cleared by U.S. FDA: | Yes |
Product Manufactured in and Exported from the U.S.: | No |
Screening Colonoscopy Artificial Intelligence Computer Aided Detection Adenoma Detection Rate |
Adenomas per Colonoscopy Surveillance Colonoscopy Colorectal Cancer Software as a Medical Device |
Polyps Pathological Conditions, Anatomical |